Moreover, since AD commonly involves both Aβ and tau pathologies, AE’s ability to simultaneously enhance lysosomal acidification and autophagosome–lysosome fusion positions it as a uniquely holistic intervention. This evidence concerns the gene MAPT and Alzheimer disease.